Guruprasad Ananda
Affiliations: | 2006-2012 | Pennsylvania State University, State College, PA, United States |
Google:
"Guruprasad Ananda"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Milind N, Preuss C, Haber A, et al. (2020) Transcriptomic stratification of late-onset Alzheimer's cases reveals novel genetic modifiers of disease pathology. Plos Genetics. 16: e1008775 |
Selvam P, Hsiao MC, Omerza G, et al. (2019) Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay. Molecular Diagnosis & Therapy |
Woo XY, Srivastava A, Graber JH, et al. (2019) Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines. Bmc Medical Genomics. 12: 92 |
Sarsani VK, Raghupathy N, Fiddes IT, et al. (2019) The Genome of C57BL/6J "Eve", the Mother of the Laboratory Mouse Genome Reference Strain. G3 (Bethesda, Md.) |
Sisson BA, Uvalic J, Kelly K, et al. (2019) Technical and Regulatory Considerations for Taking Liquid Biopsy to the Clinic: Validation of the JAX PlasmaMonitor Assay. Biomarker Insights. 14: 1177271919826545 |
Woo XY, Srivastava A, Graber JH, et al. (2019) Abstract 1075: Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): Challenges and guidelines Cancer Research. 79: 1075-1075 |
Baker CL, Walker M, Arat S, et al. (2018) Tissue-Specific Regulation of the Mouse Epigenome. Genetics |
Wang X, Philip VM, Ananda G, et al. (2018) A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer's Disease. Genetics |
Kelly KJ, Uvalic J, Bergeron D, et al. (2018) Abstract 3428: Development and validation of the plasma monitor test system Cancer Research. 78: 3428-3428 |
Helm S, Spotlow V, Ras A, et al. (2017) Abstract 757: Development and validation of the ActionSeqTMtest system Cancer Research. 77: 757-757 |